Our results reveal a novel mechanism that underlies the function of exosomal miR-141/KLF12 in SCLC angiogenesis for the first time and provide potential novel targets for anti-angiogenetic therapies for SCLC patients. The gene discussed is KLF12; the disease is small cell lung carcinoma.